Achieve Life Sciences

$9.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (+2.09%) Today
$0.00 (0.00%) As of 9:57 PM UTC after-hours

Why Robinhood?

You can buy or sell ACHV and other stocks, options, and ETFs commission-free!

About ACHV

Achieve Life Sciences, Inc. Common Shares, also called Achieve Life Sciences, is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada. The listed name for ACHV is Achieve Life Sciences, Inc. Common Shares.

CEO
John A. Bencich
Employees
14
Headquarters
Vancouver, British Columbia
Founded
1991
Market Cap
33.54M
Price-Earnings Ratio
Dividend Yield
Average Volume
437.17K
High Today
$9.50
Low Today
$8.87
Open Price
$9.19
Volume
125.76K
52 Week High
$28.00
52 Week Low
$4.51

Collections

ACHV Earnings

-$2.47
-$1.65
-$0.82
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
Available Nov 12, After Hours

You May Also Like